title: Local steroid therapy in cutaneous hemangiomas.
abstract: OBJECTIVE
  To evaluate the efficacy of intralesional triamcinolone in enhancing regression in various type of hemangiomas.
  
  
  METHODS
  Outpatients department of a teaching hospital Subjects: One hundred and five patients with rapidly growing surface hemangioma. The age ranged from 1 month to 15 months (mean 7 months).
  
  
  METHODS
  Intralesional triamcinolone administered at monthly intervals, ranging from single injection to 7 injections (mean 3.6 injections).
  
  
  METHODS
  Regression of the hemangioma.
  
  
  RESULTS
  The overall response rate was 88.6% (excellent 51.4%, and good 37.2%). Maximum response was observed in children below 1 year of age (> 90%), lesions over the face (92.8%) and strawberry hemangiomas (99.9%).
  
  
  CONCLUSIONS
  Intralesional administration of triamcinolone devoid of systemic side effects and an effective initial modality for rapidly growing hermangiomas.
authors.affiliation: Division of Pediatric Surgery and Plastic Surgery, Banaras Hindu University, Varanasi.
authors.forename: A N
authors.initials: AN
authors.lastname: Gangopadhyay
authors.forename: S P
authors.initials: SP
authors.lastname: Sharma
authors.forename: S C
authors.initials: SC
authors.lastname: Gopal
authors.forename: D K
authors.initials: DK
authors.lastname: Gupta
authors.forename: K
authors.initials: K
authors.lastname: Panjawani
authors.forename: J K
authors.initials: JK
authors.lastname: Sinha
mesh_terms: D005069:Evaluation Studies as Topic; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D015552:Injections, Intralesional; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D005938:Glucocorticoids; D014221:Triamcinolone